Oppenheimer Names 2 Stocks to Buy for the Rest of 2026
Heading into the last quarter of 2026, the big question is, what’s next? The conflicts in the Middle East remain persistent, and while oil prices h...
Innoviva Inc. (INVA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 4,036,532 | $91,669,642 | -1% | 0.13% |
| 2. | Millennium Management Israel Englander | 2,541,109 | $57,708,585 | +12% | 0.02% |
| 3. | Sarissa Capital Management Alex Denner | 1,890,604 | $42,935,617 | -12% | 24.14% |
| 4. | 36,000,000 | $38,730,778 | +95% | 0% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,454,319 | $33,027,585 | -4% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.13 | 62,000 | $814,196.40 | 7,277,000 | 2023-06-15 | Filing | |
| $13.05 | 8,000 | $104,384.00 | 7,215,000 | 2023-06-06 | Filing | |
| $13.04 | 7,000 | $91,296.80 | 7,207,000 | 2023-06-05 | Filing | |
| $13.01 | 120,000 | $1,560,648.00 | 7,200,000 | 2023-05-30 | Filing | |
| $13.12 | 30,000 | $393,729.00 | 7,080,000 | 2023-05-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.52 | 1,196,746 | $20,964,237.40 | 5,658,705 | 2025-03-06 | Filing | |
| $17.63 | 270,374 | $4,766,125.83 | 6,855,451 | 2025-03-05 | Filing | |
| $17.63 | 151,175 | $2,665,079.19 | 7,125,825 | 2025-03-04 | Filing | |
| $13.97 | 5,405 | $75,507.85 | 40,158 | 2023-11-15 | Filing | |
| $14.01 | 5,589 | $78,301.89 | 45,563 | 2023-11-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,555,209 | $262,418,797 | 0% | |
| 2. | 4,494,053 | $102,062,559 | 0.02% | |
| 3. | 4,220,273 | $95,842,400 | 0% | |
| 4. | 3,268,004 | $74,216,371 | 0% | |
| 5. | 3,158,053 | $71,719,384 | 0% |
News See All
Is Innoviva (INVA) One of the Best Cheap Small Cap Stocks to Buy Now?
Innoviva, Inc. (NASDAQ:INVA) is one of the best cheap small cap stocks to buy now. Nortiva Bio, Inc., which is a wholly owned subsidiary of Innoviva, Inc.
10 Cheap Small Cap Stocks to Buy Now
In this article, we will look at the 10 Cheap Small Cap Stocks to Buy Now.
Innoviva, Inc. (INVA) Launches Nortiva Bio to Advance Long-Acting Oral Drug Platform
We recently compiled a list of the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds. Innoviva, Inc. (NASDAQ:INVA) is one of the most promising stocks on our list.
10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds
In this article, we will be taking a look at the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds.
10 Most Profitable Undervalued Stocks to Invest In
In this article, we will discuss the 10 Most Profitable Undervalued Stocks to Invest In.
10 Best Small-Cap Value Stocks to Buy
In this article, we will look at the 10 Best Small-Cap Value Stocks to Buy.
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31 - Here's Why
Innoviva, Inc. (NASDAQ:INVA) is one of the best cheap biotech stocks to buy now. Cantor Fitzgerald lifted the price target on Innoviva, Inc.
12 Cheap Biotech Stocks to Buy Now
In this article, we will look at the 12 Cheap Biotech Stocks to Buy Now. On February 27, Eli Casdin, Casdin Capital CEO, appeared on CNBC’s ‘Closing Bell’ to talk about the biotech sector.
Innoviva, Inc. (INVA): A Bull Case Theory
We came across a bullish thesis on Innoviva, Inc on Deep-Value Stocks’s Substack. In this article, we will summarize the bulls’ thesis on INVA.
Hedge Fund Resource Center